Pictet Asset Management (Switzerland)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$8.2M	Buy	113,721 +23,854	+27%	+$1.72M	0.01%	662
2023 Q1	$6.61M	Buy	+89,867	New	+$6.61M	0.01%	713